ZNF439 expression based on
|
Comparison | Statistical significance |
Normal-vs-Primary | 1.194230E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.823700E-04 |
Normal-vs-Stage2 |
2.123400E-03 |
Normal-vs-Stage3 |
4.449900E-04 |
Normal-vs-Stage4 |
2.159500E-04 |
Stage1-vs-Stage2 |
5.076200E-01 |
Stage1-vs-Stage3 |
3.353800E-01 |
Stage1-vs-Stage4 |
2.486000E-01 |
Stage2-vs-Stage3 |
9.570400E-01 |
Stage2-vs-Stage4 |
7.143800E-01 |
Stage3-vs-Stage4 |
7.305000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.67430000000057E-05 |
Normal-vs-AfricanAmerican |
2.553000E-01 |
Normal-vs-Asian |
3.883900E-02 |
Caucasian-vs-AfricanAmerican |
1.314390E-01 |
Caucasian-vs-Asian |
1.403200E-01 |
AfricanAmerican-vs-Asian |
7.442400E-01 |
|
|
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.361800E-03 |
Normal-vs-Female |
8.37129999999853E-05 |
Male-vs-Female |
3.503600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.284100E-03 |
Normal-vs-Age(41-60Yrs) |
1.849560E-04 |
Normal-vs-Age(61-80Yrs) |
6.449400E-04 |
Normal-vs-Age(81-100Yrs) |
1.138320E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.572600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.165400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.778000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.769600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.989000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.490200E-01 |
|
|
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Classical-VS-Tall |
1.244000E-03 |
Classical-VS-Follicular |
2.933000E-01 |
Classical-VS-Other |
7.121200E-01 |
Classical-VS-Normal |
1.700290E-03 |
Tall-VS-Follicular |
7.898300E-02 |
Tall-VS-Other |
5.548000E-02 |
Tall-VS-Normal |
1.20609999998411E-06 |
Follicular-VS-Other |
5.215200E-01 |
Follicular-VS-Normal |
1.776120E-03 |
Other-VS-Normal |
3.785400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.370700E-04 |
Normal-vs-N1 |
9.87749999999954E-05 |
N0-vs-N1 |
2.331000E-01 |
|
|